Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.4899
-0.0041 (-0.83%)
At close: Jul 8, 2026, 4:00 PM EDT
0.4875
-0.0024 (-0.49%)
After-hours: Jul 8, 2026, 7:49 PM EDT
Enlivex Market Cap
Enlivex has a market cap or net worth of $115.82 million as of July 8, 2026. Its market cap has increased by 321.56% in one year.
Market Cap
115.82M
Enterprise Value
110.71M
1-Year Change
321.56%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since March 26, 2019, Enlivex's market cap has increased from $101.63M to $115.82M, an increase of 13.97%. That is a compound annual growth rate of 1.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 115.82M | -30.61% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 131.47M |
| PepGen | 130.73M |
| Aardvark Therapeutics | 130.68M |
| enGene Therapeutics | 127.95M |
| Fractyl Health | 127.86M |
| Spero Therapeutics | 126.80M |
| Polaryx Therapeutics | 125.46M |
| ProMIS Neurosciences | 122.95M |